| Hans-Günter Meyer-Thompson | International
USA. Study Finds Inadequate FDA Oversight of Monitoring of Fentanyl Products
USA. Study Finds Inadequate FDA Oversight of Monitoring of Fentanyl Products
FOIA-based investigation suggests important missed opportunities for FDA and manufacturers
A study led by researchers at the Johns Hopkins Bloomberg School of Public Health suggests that the Food and Drug Administration (FDA) and manufacturers did not take action when evidence emerged that potentially lethal fentanyl products were being inappropriately prescribed to patients.
The study was published February 19 in the Journal of the American Medical Association. (Johns Hopkins Bloomberg School of Public Health, USA, 19.02.2019)